RxSight (RXST) Amortizatization of Intangibles (2020 - 2026)
RxSight (RXST) posted Amortizatization of Intangibles of $1.9 million for Q1 2026, up 1.2% on a QoQ basis from $1.8 million in Q4 2025, and down 23.1% year-over-year from $2.4 million in Q1 2025.
RxSight (RXST) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
RxSight's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 23.1% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (down 19.46% YoY) and the FY2025 annual result came in at $8.5 million, down 5.12% from the prior year.
- Amortizatization of Intangibles was $1.9 million for Q1 2026 at RxSight, up from $1.8 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.8 million in Q3 2024 and bottomed at $47000.0 in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.7 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles surged 9675.0% — and 2025, when it plunged 30.29%.
- RxSight's Amortizatization of Intangibles stood at $783000.0 in 2022, then soared by 101.4% to $1.6 million in 2023, then jumped by 66.65% to $2.6 million in 2024, then sank by 30.29% to $1.8 million in 2025, then grew by 1.2% to $1.9 million in 2026.
- Business Quant data shows RXST's Amortizatization of Intangibles at $1.9 million in Q1 2026, $1.8 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | RxSight | 234.21 Mn | -184.00 Mn | 23.50 Mn | 1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.85 Mn |
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Dec 31, 2023 | 1.58 Mn |